• FPH1 (BRD-6125) Hepatocyte Workflow Guide

  2026-09-11

  Learn how to use FPH1 (BRD-6125) to expand functional primary human hepatocytes while tracking albumin, CYP3A4, AFP, nuclei count, and mitotic activity. The workflow also shows how FPH1 can complement iPS-cell hepatocyte differentiation and how light-controlled gene regulation may inform future hepatic assay design.

• Dual-Action p38α MAPK Inhibitors and Dephosphorylation

  2026-09-11

  The reference preprint shows that selected p38α MAP kinase inhibitors can both inhibit catalytic activity and accelerate WIP1-mediated removal of the activation-loop phosphate. Biochemical experiments and X-ray structures connect this effect to an inhibitor-stabilized conformation that exposes the phospho-threonine, offering a framework for designing more selective kinase inhibitors.

• Cyanine 5-dCTP for Quantitative DNA Assays

  2026-09-10

  Cyanine 5-dCTP enables covalent red-fluorescent labeling during enzymatic DNA synthesis. This article connects Cy5-dCTP chemistry with primer architecture, assay controls, and practical decisions for quantitative nucleic acid detection.

• E. coli Uracil-DNA Glycosylase (UDG) Guide

  2026-09-10

  E. coli Uracil-DNA Glycosylase (UDG), SKU K1107, excises uracil from single- and double-stranded DNA to support PCR product contamination elimination and controlled DNA repair research. It is intended for scientific research DNA workflows, not RNA, oligonucleotides shorter than six bases, diagnostic testing, or medical use.

• Mitomycin C Workflows for Cancer Research

  2026-09-09

  Build reproducible Mitomycin C assays for DNA replication inhibition, apoptosis signaling research, and TRAIL-sensitization studies. This guide also shows how to cautiously connect cytotoxicity workflows with the DC–CD8+ T-cell–NK-cell framework described in a tumor-vaccine study.

• Ibuprofen and Naproxen Synthesis: Recent Advances

  2026-09-09

  Ha and Paek’s review maps how modern synthetic chemistry has improved access to ibuprofen and naproxen through shorter, more practical, asymmetric, derivative-oriented, and continuous-flow routes. Its main value is connecting established NSAID structures with process intensification and stereochemical control, providing a useful framework for researchers planning synthetic or medicinal chemistry studies.

• Trypsin-Responsive Nanomedicine for Acute Pancreatitis

  2026-09-08

  Wang and colleagues developed a biomimetic mesoporous organosilica nanoparticle that combines pancreatic acinar-cell targeting with trypsin-triggered BAPTA-AM release. In a mouse model of acute pancreatitis, the formulation reduced intracellular calcium overload, suppressed inflammatory and necrotic signaling, improved pancreatic enzyme profiles, and increased survival, while also illustrating the manufacturing and translational challenges of precision nanomedicine.

• S-Adenosylhomocysteine in Neural Assay Design

  2026-09-08

  S-Adenosylhomocysteine can turn methylation balance into a testable variable in radiation-neurobiology experiments. This article presents a ratio-aware assay framework that separates metabolic feedback from PI3K-STAT3-mGluR1-driven neuronal phenotypes.

• HotStart Universal 2X Green qPCR Master Mix

  2026-09-07

  HotStart Universal 2X Green qPCR Master Mix supports dye-based real-time PCR gene expression analysis with hot-start Taq polymerase, Green I fluorescence, and a universal ROX reference dye. It provides a practical workflow for gene expression quantification while requiring melt curve analysis to distinguish specific amplicons from nonspecific products.

• cck8 Workflow for NSCLC Viability Studies

  2026-09-07

  Build a reproducible cck8 workflow for NSCLC drug-response studies, from seeding and calibration to troubleshooting metabolic interference. The Cell Counting Kit-8 connects rapid viability screening with mechanistic experiments on bornyl acetate, PI3K/AKT signaling, and ABCB1-associated resistance.

• VX-702 and the Next Era of p38α Translation

  2026-09-05

  VX-702 offers translational researchers a selective, ATP-competitive route to interrogate p38α MAPK biology across cytokine, platelet, arthritis, and cardiac injury models. By connecting product pharmacology with emerging evidence on kinase conformational control and phosphatase-driven deactivation, this article presents a strategy for turning pathway inhibition into more informative experimental decisions.

• Mifepristone (RU486) in Integrated Bioassays

  2026-09-04

  Mifepristone (RU486) is more than a progesterone receptor antagonist: it is a versatile probe for linking receptor biology, cell fate, and functional toxicity. This article presents an integrated assay strategy that connects cancer and reproductive endpoints with transcriptomic and phenotypic cardiomyocyte screening.

• HyperScript™ Reverse Transcriptase for Adipose RNA

  2026-09-04

  HyperScript™ Reverse Transcriptase supports reliable RNA-to-cDNA conversion when adipose-tissue transcripts are scarce, long, or structurally difficult. Its thermal stability, reduced RNase H activity, and RNA-template affinity make it a practical choice for qPCR panels investigating Netrin-1, PPARγ, and Wnt/β-catenin signaling.

• Degarelix Acetate: From Binding to Biology

  2026-09-03

  Degarelix acetate is a potent GnRH receptor antagonist whose biological impact depends on more than receptor potency alone. This article connects binding, functional signaling, hormone secretion inhibition, and duration of action to improve assay interpretation in prostate cancer research.

• Auranofin, Redox Stress, and Translational Strategy

  2026-09-03

  Auranofin is more than a thioredoxin reductase inhibitor: it is a mechanistic probe for testing how redox vulnerability, apoptosis, radiation response, and cytoskeleton-dependent autophagy intersect. This thought-leadership guide translates the available evidence into experimental decision points for cancer research and mechanobiology.

8551 records 1/571 page Next 12345 下5页 Last page